Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/RI/Providence

Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Providence, RI

Studies commonly pay $75 to $4,500 per completed study

550 clinical trials are currently recruiting participants within 30 miles of Providence. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

550studies recruiting

9+research centers nearby

6condition categories

Live from the NIH registry

Studies recruiting near Providence right now

Top 25 of 550 recruiting studies, sorted by proximity — each links to its official registry page

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Advanced Solid Tumors Phase 1, Phase 2 Interventional 83 participants sought

Rhode Island Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: Jiangsu HengRui Medicine Co., Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT05277168)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought

Rhode Island Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

Migraine Phase 2 Interventional 488 participants sought

Velocity Clinical Research, Providence (East Greenwich) — East Greenwich, Rhode Island (11.4 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT06602479)

Alpha-1 Blockade for Alcohol Use Disorder (AUD)

Alcohol Use Disorder (AUD) Phase 2 Interventional 184 participants sought

Brown University — Providence, Rhode Island (0.3 mi) · Sponsor: Brown University

See eligibility & contact on ClinicalTrials.gov (NCT04135846)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought

Lifespan Cancer Institute — Providence, Rhode Island (0.3 mi) · Sponsor: Regeneron Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT06465329)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought

Research Site — Providence, Rhode Island (0.3 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought

Providence Veterans Administration Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Ulcerative Colitis, Crohn's Disease Phase 3 Interventional 240 participants sought

Hasbro Children's Hospital - PIN — Providence, Rhode Island (0.3 mi) · Sponsor: Takeda

See eligibility & contact on ClinicalTrials.gov (NCT05442567)

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Acute HIV Infection Phase 2 Interventional 48 participants sought

2951, The Miriam Hospital (TMH) CRS — Providence, Rhode Island (0.3 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

See eligibility & contact on ClinicalTrials.gov (NCT05719441)

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Early Onset Alzheimer Disease, Alzheimer Disease N/A Observational 850 participants sought

Butler Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: Indiana University

See eligibility & contact on ClinicalTrials.gov (NCT03507257)

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Alzheimer Disease, Early Onset, Mild Cognitive Impairment Phase 1 Interventional 35 participants sought

Memory and Aging Program, Butler Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: Butler Hospital

See eligibility & contact on ClinicalTrials.gov (NCT04500847)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought

Rhode Island Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05564390)

E-Mindfulness Approaches for Living After Breast Cancer

Breast Cancer, Depression Phase 3 Interventional 402 participants sought

Women and Infants Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06748222)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought

Rhode Island Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05099003)

Cannabis' Impact on Alcohol Consumption

Alcohol Drinking, Cannabis Use Phase 2 Interventional 350 participants sought

Brown University — Providence, Rhode Island (0.3 mi) · Sponsor: Brown University

See eligibility & contact on ClinicalTrials.gov (NCT05389930)

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought

Women and Infants Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05646316)

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

Locally Advanced Cervical Cancer Phase 3 Interventional 800 participants sought

Research Site — Providence, Rhode Island (0.3 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06079671)

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

Rectal Cancer, Rectal Tumor N/A Interventional 250 participants sought

Lifespan & Brown Surgical Associates — Providence, Rhode Island (0.3 mi) · Sponsor: Colospan Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT04184973)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought

Rhode Island Hospital — Providence, Rhode Island (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05675410)

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

Preterm Delivery, Obstetrical Complications Phase 3 Interventional 1,800 participants sought

Brown University — Providence, Rhode Island (0.3 mi) · Sponsor: The George Washington University Biostatistics Center

See eligibility & contact on ClinicalTrials.gov (NCT06980025)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis N/A Observational 1,000 participants sought

Galderma Investigationa Site 7104 — Milford, Massachusetts (22.5 mi) · Sponsor: Galderma R&D

See eligibility & contact on ClinicalTrials.gov (NCT06988605)

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Chronic Obstructive Pulmonary Disease, Pulmonary Hypertension Phase 2 Interventional 126 participants sought

Providence VA Medical Center, Providence, RI — Providence, Rhode Island (0.3 mi) · Sponsor: VA Office of Research and Development

See eligibility & contact on ClinicalTrials.gov (NCT05937854)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 714 participants sought

Southcoast Centers for Cancer Care — Fall River, Massachusetts (16.0 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT06758401)

Probenecid Administration for Alcohol Craving and Consumption

Alcohol Use Disorder (AUD), Alcohol Consumption Phase 2 Interventional 120 participants sought

Brown University — Providence, Rhode Island (0.3 mi) · Sponsor: Brown University

See eligibility & contact on ClinicalTrials.gov (NCT07118618)

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Breast Cancer, Triple Negative Breast Cancer Phase 2 Interventional 110 participants sought

DFCI @ Foxborough — Foxborough, Massachusetts (18.9 mi) · Sponsor: Dana-Farber Cancer Institute

See eligibility & contact on ClinicalTrials.gov (NCT04468061)

Actively enrolling

Studies you may be able to join near Providence

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Providence

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Ocean State Clinical Coordinating Center

1 Virginia Ave Ste 105, Providence, RI 02905

(401) 444-1488

Website

Weight Control & Diabetes Research Center

★ 4.2

196 Richmond St, Providence, RI 02903

(401) 793-8950

Brown Center for Biomedical Informatics

233 Richmond St, Providence, RI 02912

(401) 863-1000

Website

Clinical Partners

★ 5.0

1524 Atwood Ave #330, Johnston, RI 02919

(401) 454-3800

Website

"Staff knowledgeable and professional.<br>Very helpful regard the study your in .<br>I just want to say to the staff big THANK YOU.for your help you g…"

— Mitch Medeiros, 5★

K2 Medical Research - East Providence

1018 Waterman Ave, East Providence, RI 02914

(401) 955-5252

Website

Brown University Health Community Health Institute

★ 5.0

335R Prairie Ave #2b, Providence, RI 02905

(401) 444-8009

Website

Lifespan ClinTECH

1 Hoppin St, Providence, RI 02903

Website

Brown University Health Cancer Institute at Rhode Island Hospital

★ 4.1 (24 reviews)

Ambulatory Patient Center, 593 Eddy St, Providence, RI 02903

(844) 222-2881

Website

"Very satisfied with everyone on the second floor. Made you very comfortable, had a young come around with a snack and sandwich cart. Everyone very …"

— Richard Wain Jr, 5★

Roger Williams Medical Center

★ 3.8

825 Chalkstone Ave, Providence, RI 02908

(401) 456-2000

Website

Clinical trials in Providence: what's recruiting

The Providence area currently has 550 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Providence, the most active research areas are:

Cancer & Oncology14 studies
Brain & Mental Health3 studies
Immune & Skin2 studies
Liver & Kidney1 studies
Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Providence, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Providence

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Providence participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Providence pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Providence?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Providence safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Providence, RI?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Paid clinical trials near Providence

Other metros within reach

New Bedford, MA511 Worcester, MA269 Boston, MA2,944 Norwich, CT122 Nashua, NH254 Springfield, MA325 Manchester, NH89 Hartford, CT447

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts